Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles. [PDF]
Kleinendorst SC +12 more
europepmc +1 more source
Gravity versus pump-driven infusion in targeted radionuclide therapy: a model-based dosimetric evaluation of extravasation. [PDF]
Lienhardt O +7 more
europepmc +1 more source
Direct estimation of activity concentration in regional voxels with application to <sup>177</sup>Lu peptide receptor radionuclide therapy. [PDF]
Gustafsson J +2 more
europepmc +1 more source
Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome. [PDF]
Pandit R +5 more
europepmc +1 more source
A Targeted Radionuclide Therapy Facility at a University Teaching Hospital in Singapore. [PDF]
Chia KL +6 more
europepmc +1 more source
Emergence of a barium metal-organic framework for mitigating off-target effects of alpha radionuclide therapy. [PDF]
Qiu L +11 more
europepmc +1 more source
Low Radioactivity Levels in Blood Samples After Targeted Radionuclide Therapy: Minimal Radiation Exposure of Healthcare Staff. [PDF]
Wehmann M +5 more
europepmc +1 more source
Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis. [PDF]
Abdlkadir AS +7 more
europepmc +1 more source
<sup>212</sup>Pb in targeted radionuclide therapy: a review. [PDF]
Scaffidi-Muta JM, Abell AD.
europepmc +1 more source
<sup>177</sup>Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis. [PDF]
Wang J, Pang X, Lian J, Lu H.
europepmc +1 more source

